Key result
Standard HF therapy and diuresis improve LVEF by ~18 points in myocarditis-induced DCM.
Case Report (n=1)
No
This case highlights that viral myocarditis can present with acute kidney injury via type 1 cardiorenal syndrome and that cardiac MRI is crucial for diagnosing reversible dilated cardiomyopathy when obesity limits echocardiographic image quality.
Answers are grounded in this paper and cite their sources.
May support LVEF recovery with standard therapy in myocarditis-induced DCM; leaves open generalizability and need for prospective trials.
A 24-year-old Nepali man presented to hospital with a short history of feeling unwell with a flu-like illness. He subsequently went into acute renal failure requiring several sessions of renal replacement therapy by haemofiltration. The underlying aetiology of his renal failure was unclear. His renal function recovered following haemofiltration and he was discharged home with a plan for outpatient follow-up and investigations. He re-presented to hospital 6 days later with severe fluid overload. Echocardiogram was suggestive of impaired left ventricular systolic function; subsequent cardiac MRI confirmed this and was indicative of a dilated cardiomyopathy. A diagnosis of dilated cardiomyopathy with cardiorenal syndrome was made, most likely secondary to viral myocarditis in view of his initial presentation. He was diuresed and treated with prognostic medications for heart failure. His symptoms resolved and on subsequent outpatient review he was feeling well.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2015) conducted a case report in Dilated cardiomyopathy with cardiorenal syndrome secondary to suspected viral myocarditis (n=1). Diuresis (furosemide infusion, fluid restriction, pleural and ascitic drainage) and standard heart failure therapy (ACE inhibitor, beta-blocker, spironolactone) was evaluated on Left ventricular ejection fraction and symptom resolution at 3-month follow-up. Diuresis and standard heart failure therapy (ACE inhibitor, beta-blocker, spironolactone) improved LVEF from 38.0% to 56.4% on cardiac MRI at 3 months in a man with myocarditis-induced DCM.
Synapse has enriched 10 related papers. Consider them for comparative context: